National Comprehensive Cancer Network

Home | About NCCN | Find a Member Institution | Login/Register | Contact Us

NCCN eBulletin Newsletter

News

NCCN eBulletin Advertising Information

NCCN eBulletin International Edition Advertising Information

NCCN eBulletin: International Edition

NCCN Leadership

NCCN Foundation

NCCN Corporate Council

Employment Opportunities

Supporter and Exhibitor Opportunities

Advertising Opportunities

Permissions Requests

Permissions

Legal Notice about NCCN Content

NCCN Content

Citation Information

Link to NCCN Website

Order a copy of the NCCN flash drive

NCCN Disclosure Policies & Potential Conflicts of Interest

Disclosure Policy for the NCCN Guidelines Panels

Disclosure Policy for the NCCN Oncology Research Program (ORP)

Identifications and Disclosures of Relationships with External Entities

Disclosure of NCCN Organizational Relationships

NCCN Annual Report

NCCN History

Supporter Opportunities

About NCCN

Central Nervous System Cancers Panel - Disclosures as of 6/10/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Philip J. Bierman, MD	None	None	None	None	5/1/2013
Peter McLaren Black, MD, PhD	None	None	None	None	11/9/2009
Henry Brem, MD	None	None	None	None	9/27/2012
Steven Brem, MD	None	Eisai, Inc.	None	None	3/25/2011
Nicholas Butowski, MD	None	None	None	None	8/9/2012
Marc C. Chamberlain, MD	NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas	Enzon Pharmaceuticals; Exelixis Inc.; Genentech, Inc.; Schering-Plough Corporation	None	None	8/9/2012
E. Antonio Chiocca, MD, PhD	None	None	None	None	6/23/2011
Lisa M. DeAngelis, MD	None	Genentech, Inc.	None	None	8/20/2012
Robert A. Fenstermaker, MD	None	None	None	None	8/9/2012
Allan Friedman, MD	None	None	None	None	9/26/2012
Lauren Gallagher, RPh, PhD	None	None	None	None	6/5/2012
Mark R. Gilbert, MD	RTOG Trial	Genentech, Inc.; Pfizer Inc.; Schering-Plough Corporation	None	None	8/9/2012
Kristina M. Gregory, RN, MSN, OCN	None	None	None	None	10/23/2012
Deneen Hesser, MSHSA, RN, OCN	None	None	None	None	9/27/2012
Maria Ho, PhD	None	None	None	None	8/3/2012
Larry Junck, MD	None	Genentech, Inc.	None	None	3/14/2013
Gerald P. Linette, MD, PhD	None	None	None	None	7/28/2011
Jay S. Loeffler, MD	None	Genentech, Inc.; ProCure; TransMolecular	None	None	7/16/2012
Moshe H. Maor, MD	None	None	None	None	8/24/2012
Joan S. McClure, MS	None	None	None	None	7/23/2012
Nicole McMillian, MS	None	None	None	None	3/27/2013
L. Madison Michael, II, MD	None	None	None	None	7/13/2011
Paul L. Moots, MD	None	None	None	None	10/9/2012
Tara Morrison, MD, FRCPC	None	Genentech, Inc.	None	None	10/1/2012
Maciej M. Mrugala, MD, PhD, MPH	None	Enzon Pharmaceuticals; Schering-Plough Corporation	None	None	11/24/2009
Louis Burt Nabors, MD	AstraZeneca Pharmaceuticals LP; Genentech, Inc.; Merck KGaA; Transmolecular	Merck KGaA	None	None	3/3/2013
Herbert B. Newton, MD	None	Eisai Inc.; UCB Pharma; Schering-Plough Corporation	None	None	8/16/2012
Jana Portnow, MD	None	None	None	None	11/28/2012
Jeffrey J. Raizer, MD	None	Enzon Pharmaceuticals; Genentech, Inc.; Schering-Plough Corporation	None	None	10/3/2012
Lawrence Recht, MD	None	Genentech, Inc.	None	None	2/27/2013
Dennis C. Shrieve, MD, PhD	None	None	None	None	2/26/2013
Allen K. Sills, MD	None	None	None	None	10/5/2011
Frank D. Vrionis, MD, MPH, PhD	None	Medtronic, Inc.; Florida Board of Medicine; Orthopix; Southeastern Brain Tumor Association	None	None	11/13/2012